Valproate Sodium Injection Shortage
Last Updated: July 12, 2019
Status: Resolved
Products Affected - Description
-
- Depacon injection, AbbVie, 100 mg/mL, 5 mL vial, 10 count, NDC 00074-1564-10 - discontinued
Reason for the Shortage
-
- Abbvie discontinued Depacon in May 2019.
- Hikma did not provide a reason for the shortage.
- Fresenius Kabi did not provide a reason for the shortage.
Available Products
-
- Valproate Sodium injection, Fresenius Kabi, 100 mg/mL, 5 mL vial, 10 count, NDC 63323-0494-05
- Valproate Sodium injection, Hikma, 100 mg/mL, 5 mL vial, 10 count, NDC 00143-9785-10
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated July 12, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 29, 2019 by Stephen Andrews, PharmD, BCPS, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.